Schedule 13D ownership disclosure

Talis Biomedical Corp

Security class unavailable · CUSIP: 87424L108

Event date: 2021-03-26

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
37,432,057
Percent of class
67.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-21-046072
Form type
SC 13D/A
Filer
BAKER BROS. ADVISORS LP
CIK
CIK 1263508
Filed
Apr 02, 2021
Reporting period
Mar 26, 2021
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub